That inconsistency weakens state data collection and makes it difficult to look for patterns in chronic absenteeism, Chang said. “I’ve talked to a superintendent who said, ‘That’s not fair ...

The CEO of Flow Neuroscience has called out the US Food and Drug Administration (FDA) for market entry delays for clinically ...